Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Noble

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Toxicology Letters|January 9, 2013
Comparison of tolerance to morphine-induced respiratory and analgesic effects in miceWasseem Mohammed, Hisham Alhaddad, Nicolas Marie, et al.
Pain|February 20, 1998
Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120Florence Noble, Claire Smadja, Olga Valverde, et al.
Toxicology and Applied Pharmacology|September 20, 2005
Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilationBruno Mégarbane, Nicolas Marie, Stéphane Pirnay, et al.
Addiction Biology|January 12, 2017
Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependenceSabah Kelaï, Nicolas Ramoz, Jean-Marie Moalic, et al.
European Journal of Pharmacology|June 25, 2002
Depressant effect on a C-fibre reflex in the rat, of RB101, a dual inhibitor of enkephalin-degrading enzymesJean-Michel Benoist, Florence Keime, Jacqueline Montagne, et al.
Psychopharmacology|April 8, 2014
Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing propertiesMarianne Seleman, Hélène Chapy, Salvatore Cisternino, et al.
Presse Medicale (Paris, France : 1983)|December 25, 2007
[Current pharmacotherapies and immunotherapy in cocaine addiction]Laurent Karila, Aviv Weinstein, Amine Benyamina, et al.
Pain|July 12, 2003
Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadoneStéphanie Le Guen, Magdalena Mas Nieto, Corinne Canestrelli, et al.
The International Journal of Neuropsychopharmacology|October 12, 2007
New treatments for cocaine dependence: a focused reviewLaurent Karila, David Gorelick, Aviv Weinstein, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 13, 2026
Traumatic-like fear memory recall causes persistent morphine conditioned place preference in drug withdrawn male miceClaire Leconte, Virginie Beray-Berthat, Fanny Saulnier, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Toxicology Letters|January 9, 2013
Comparison of tolerance to morphine-induced respiratory and analgesic effects in miceWasseem Mohammed, Hisham Alhaddad, Nicolas Marie, et al.
Pain|February 20, 1998
Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120Florence Noble, Claire Smadja, Olga Valverde, et al.
Toxicology and Applied Pharmacology|September 20, 2005
Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilationBruno Mégarbane, Nicolas Marie, Stéphane Pirnay, et al.
Addiction Biology|January 12, 2017
Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependenceSabah Kelaï, Nicolas Ramoz, Jean-Marie Moalic, et al.
European Journal of Pharmacology|June 25, 2002
Depressant effect on a C-fibre reflex in the rat, of RB101, a dual inhibitor of enkephalin-degrading enzymesJean-Michel Benoist, Florence Keime, Jacqueline Montagne, et al.
Psychopharmacology|April 8, 2014
Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing propertiesMarianne Seleman, Hélène Chapy, Salvatore Cisternino, et al.
Presse Medicale (Paris, France : 1983)|December 25, 2007
[Current pharmacotherapies and immunotherapy in cocaine addiction]Laurent Karila, Aviv Weinstein, Amine Benyamina, et al.
Pain|July 12, 2003
Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadoneStéphanie Le Guen, Magdalena Mas Nieto, Corinne Canestrelli, et al.
The International Journal of Neuropsychopharmacology|October 12, 2007
New treatments for cocaine dependence: a focused reviewLaurent Karila, David Gorelick, Aviv Weinstein, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 13, 2026
Traumatic-like fear memory recall causes persistent morphine conditioned place preference in drug withdrawn male miceClaire Leconte, Virginie Beray-Berthat, Fanny Saulnier, et al.
Pageof 8